lilly retatrutide trial New Phase 3 data just dropped ๐ Eli Lilly's reported average weight loss approaching 30%, with some patients achieving results historically associated with bariatric surgery. A few important caveats Retatrutide clinical trial done! Now
Description
Should these patients go on to develop PDR, they need to be referred to ophthalmology for anti-VEGF or PRP
Kidney disease and increased mortality risk in type 2 diabetes
Methods: We conducted a retrospective nested case-control study using the All of Us Research Program data
Like these kind of feel good stories
These results underscore its potential as a powerful tool for managing hyperglycemia and are supported by its ongoing evaluation in advanced clinical trials
Trying to decide between Ozempic and metformin
